Preformulation and characterization of a lidocaine hydrochloride and dexamethasone sodium phosphate thermo-reversible and bioadhesive long-acting gel for intraperitoneal administration
[Display omitted] The search for new formulations of anaesthetic agents that allow a localized administration and provide a prolonged effect is of great interest in the multimodal management of postoperative pain. The pre-formulation and characterization of a lidocaine and dexamethasone thermosensit...
Gespeichert in:
Veröffentlicht in: | International journal of pharmaceutics 2016-02, Vol.498 (1-2), p.142-152 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 152 |
---|---|
container_issue | 1-2 |
container_start_page | 142 |
container_title | International journal of pharmaceutics |
container_volume | 498 |
creator | Arbelaez-Camargo, Diana Suñé-Negre, Josep Maria Roig-Carreras, Manel García-Montoya, Encarna Pérez-Lozano, Pilar Miñarro-Carmona, Montserrat Ticó-Grau, Josep Ramon |
description | [Display omitted]
The search for new formulations of anaesthetic agents that allow a localized administration and provide a prolonged effect is of great interest in the multimodal management of postoperative pain. The pre-formulation and characterization of a lidocaine and dexamethasone thermosensitive and bioadhesive long-acting gel for intraperitoneal administration was done as a tool in the management of pain in abdominal surgeries. The pre-formulation process was conducted by a systematic variation of the concentration of the different polymers, until setting it, in a suitable concentration that allowed an adequate gelation temperature. The poloxamer 407 (P407) was used as the main polymer; hydroxypropyl methylcellulose (HPMC) as the bioadhesive agent and polyvinyl pyrrolidone (PVP) to adjust the gelation temperature and physicochemical properties. The formulations were characterized by gelation temperature, pH, viscosity at 25°C and 37°C, gelation time, density and osmolality. Gelation temperature was decreased when increasing the concentration of hydroxypropyl methylcellulose and poloxamer 407, this effect was also observed when adding lidocaine hydrochloride and dexamethasone sodium phosphate to the formulations. The gelation temperature did not have statistically significant relation with the PVP concentration (P-value of 0.6797), even though, there is a tendency in the gelation temperature by varying it. Between the developed formulations, the 12.5/3.3/0.4% (P407/HPMC/PVP) formulation presents an appropriate gelation temperature, a suitable viscosity for administration by syringe, an adequate and stable pH and osmolality to prevent tissue damage and a correct gelation time that allowed the formation of a prolonged release implant. |
doi_str_mv | 10.1016/j.ijpharm.2015.12.012 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1760930540</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517315304130</els_id><sourcerecordid>1760930540</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-f05d5df28279236f2773113ff04bf6017e50a66764f31a9483fe3672e7bdab663</originalsourceid><addsrcrecordid>eNqFUctu1DAUtRCIDoVPAHnJJsGPxM6sEKoKRaoEC1hbjn098ciJg52MWr6Mz8NDBrasrnTvedkHodeU1JRQ8e5Y--M86DTWjNC2pqwmlD1BO9pJXvFGiqdoR7jsqpZKfoVe5HwkhAhG-XN0xYToWsnEDv36msDFNK5BLz5OWE8WmyKrzQLJ_9yW0WGNg7fRaD8BHh5timYIMXkLfxgWHvQIy6BzLPccrV9HPA8xl4QL4GWANMYqwQlS9n3YSL2P2g6Q_QlwiNOhKp5-OuADBFwiYT8tSc8lxVJEdcDajn7yuSzPoV6iZ06HDK8u8xp9_3j77eauuv_y6fPNh_vK8D1dKkda21rHOib3jAvHpOSUcudI0ztBqISWaCGkaBynet903AEXkoHsre6F4Nfo7aY7p_hjhbyo0WcDIegJ4poVlYLsOWkbUqDtBjUp5lz-Vc3Jjzo9KkrUuTR1VJfS1Lk0RZkqpRXem4vF2o9g_7H-tlQA7zcAlIeePCSVjYfJgPUJzKJs9P-x-A3Q37EY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1760930540</pqid></control><display><type>article</type><title>Preformulation and characterization of a lidocaine hydrochloride and dexamethasone sodium phosphate thermo-reversible and bioadhesive long-acting gel for intraperitoneal administration</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Arbelaez-Camargo, Diana ; Suñé-Negre, Josep Maria ; Roig-Carreras, Manel ; García-Montoya, Encarna ; Pérez-Lozano, Pilar ; Miñarro-Carmona, Montserrat ; Ticó-Grau, Josep Ramon</creator><creatorcontrib>Arbelaez-Camargo, Diana ; Suñé-Negre, Josep Maria ; Roig-Carreras, Manel ; García-Montoya, Encarna ; Pérez-Lozano, Pilar ; Miñarro-Carmona, Montserrat ; Ticó-Grau, Josep Ramon</creatorcontrib><description>[Display omitted]
The search for new formulations of anaesthetic agents that allow a localized administration and provide a prolonged effect is of great interest in the multimodal management of postoperative pain. The pre-formulation and characterization of a lidocaine and dexamethasone thermosensitive and bioadhesive long-acting gel for intraperitoneal administration was done as a tool in the management of pain in abdominal surgeries. The pre-formulation process was conducted by a systematic variation of the concentration of the different polymers, until setting it, in a suitable concentration that allowed an adequate gelation temperature. The poloxamer 407 (P407) was used as the main polymer; hydroxypropyl methylcellulose (HPMC) as the bioadhesive agent and polyvinyl pyrrolidone (PVP) to adjust the gelation temperature and physicochemical properties. The formulations were characterized by gelation temperature, pH, viscosity at 25°C and 37°C, gelation time, density and osmolality. Gelation temperature was decreased when increasing the concentration of hydroxypropyl methylcellulose and poloxamer 407, this effect was also observed when adding lidocaine hydrochloride and dexamethasone sodium phosphate to the formulations. The gelation temperature did not have statistically significant relation with the PVP concentration (P-value of 0.6797), even though, there is a tendency in the gelation temperature by varying it. Between the developed formulations, the 12.5/3.3/0.4% (P407/HPMC/PVP) formulation presents an appropriate gelation temperature, a suitable viscosity for administration by syringe, an adequate and stable pH and osmolality to prevent tissue damage and a correct gelation time that allowed the formation of a prolonged release implant.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2015.12.012</identifier><identifier>PMID: 26685726</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adhesiveness ; Adhesives - chemistry ; Bioadhesive ; Chemistry, Pharmaceutical ; Controlled release ; Delayed-Action Preparations - chemistry ; Dexamethasone ; Dexamethasone - analogs & derivatives ; Dexamethasone - chemistry ; Gels ; Injections, Intraperitoneal ; Intraperitoneal administration ; Lidocaine ; Lidocaine - chemistry ; Poloxamer - chemistry ; Poloxamer 407 ; Temperature ; Thermoreversible gel ; Viscosity</subject><ispartof>International journal of pharmaceutics, 2016-02, Vol.498 (1-2), p.142-152</ispartof><rights>2015 Elsevier B.V.</rights><rights>Copyright © 2015 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-f05d5df28279236f2773113ff04bf6017e50a66764f31a9483fe3672e7bdab663</citedby><cites>FETCH-LOGICAL-c391t-f05d5df28279236f2773113ff04bf6017e50a66764f31a9483fe3672e7bdab663</cites><orcidid>0000-0001-6245-5666</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0378517315304130$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26685726$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arbelaez-Camargo, Diana</creatorcontrib><creatorcontrib>Suñé-Negre, Josep Maria</creatorcontrib><creatorcontrib>Roig-Carreras, Manel</creatorcontrib><creatorcontrib>García-Montoya, Encarna</creatorcontrib><creatorcontrib>Pérez-Lozano, Pilar</creatorcontrib><creatorcontrib>Miñarro-Carmona, Montserrat</creatorcontrib><creatorcontrib>Ticó-Grau, Josep Ramon</creatorcontrib><title>Preformulation and characterization of a lidocaine hydrochloride and dexamethasone sodium phosphate thermo-reversible and bioadhesive long-acting gel for intraperitoneal administration</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>[Display omitted]
The search for new formulations of anaesthetic agents that allow a localized administration and provide a prolonged effect is of great interest in the multimodal management of postoperative pain. The pre-formulation and characterization of a lidocaine and dexamethasone thermosensitive and bioadhesive long-acting gel for intraperitoneal administration was done as a tool in the management of pain in abdominal surgeries. The pre-formulation process was conducted by a systematic variation of the concentration of the different polymers, until setting it, in a suitable concentration that allowed an adequate gelation temperature. The poloxamer 407 (P407) was used as the main polymer; hydroxypropyl methylcellulose (HPMC) as the bioadhesive agent and polyvinyl pyrrolidone (PVP) to adjust the gelation temperature and physicochemical properties. The formulations were characterized by gelation temperature, pH, viscosity at 25°C and 37°C, gelation time, density and osmolality. Gelation temperature was decreased when increasing the concentration of hydroxypropyl methylcellulose and poloxamer 407, this effect was also observed when adding lidocaine hydrochloride and dexamethasone sodium phosphate to the formulations. The gelation temperature did not have statistically significant relation with the PVP concentration (P-value of 0.6797), even though, there is a tendency in the gelation temperature by varying it. Between the developed formulations, the 12.5/3.3/0.4% (P407/HPMC/PVP) formulation presents an appropriate gelation temperature, a suitable viscosity for administration by syringe, an adequate and stable pH and osmolality to prevent tissue damage and a correct gelation time that allowed the formation of a prolonged release implant.</description><subject>Adhesiveness</subject><subject>Adhesives - chemistry</subject><subject>Bioadhesive</subject><subject>Chemistry, Pharmaceutical</subject><subject>Controlled release</subject><subject>Delayed-Action Preparations - chemistry</subject><subject>Dexamethasone</subject><subject>Dexamethasone - analogs & derivatives</subject><subject>Dexamethasone - chemistry</subject><subject>Gels</subject><subject>Injections, Intraperitoneal</subject><subject>Intraperitoneal administration</subject><subject>Lidocaine</subject><subject>Lidocaine - chemistry</subject><subject>Poloxamer - chemistry</subject><subject>Poloxamer 407</subject><subject>Temperature</subject><subject>Thermoreversible gel</subject><subject>Viscosity</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUctu1DAUtRCIDoVPAHnJJsGPxM6sEKoKRaoEC1hbjn098ciJg52MWr6Mz8NDBrasrnTvedkHodeU1JRQ8e5Y--M86DTWjNC2pqwmlD1BO9pJXvFGiqdoR7jsqpZKfoVe5HwkhAhG-XN0xYToWsnEDv36msDFNK5BLz5OWE8WmyKrzQLJ_9yW0WGNg7fRaD8BHh5timYIMXkLfxgWHvQIy6BzLPccrV9HPA8xl4QL4GWANMYqwQlS9n3YSL2P2g6Q_QlwiNOhKp5-OuADBFwiYT8tSc8lxVJEdcDajn7yuSzPoV6iZ06HDK8u8xp9_3j77eauuv_y6fPNh_vK8D1dKkda21rHOib3jAvHpOSUcudI0ztBqISWaCGkaBynet903AEXkoHsre6F4Nfo7aY7p_hjhbyo0WcDIegJ4poVlYLsOWkbUqDtBjUp5lz-Vc3Jjzo9KkrUuTR1VJfS1Lk0RZkqpRXem4vF2o9g_7H-tlQA7zcAlIeePCSVjYfJgPUJzKJs9P-x-A3Q37EY</recordid><startdate>20160210</startdate><enddate>20160210</enddate><creator>Arbelaez-Camargo, Diana</creator><creator>Suñé-Negre, Josep Maria</creator><creator>Roig-Carreras, Manel</creator><creator>García-Montoya, Encarna</creator><creator>Pérez-Lozano, Pilar</creator><creator>Miñarro-Carmona, Montserrat</creator><creator>Ticó-Grau, Josep Ramon</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6245-5666</orcidid></search><sort><creationdate>20160210</creationdate><title>Preformulation and characterization of a lidocaine hydrochloride and dexamethasone sodium phosphate thermo-reversible and bioadhesive long-acting gel for intraperitoneal administration</title><author>Arbelaez-Camargo, Diana ; Suñé-Negre, Josep Maria ; Roig-Carreras, Manel ; García-Montoya, Encarna ; Pérez-Lozano, Pilar ; Miñarro-Carmona, Montserrat ; Ticó-Grau, Josep Ramon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-f05d5df28279236f2773113ff04bf6017e50a66764f31a9483fe3672e7bdab663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adhesiveness</topic><topic>Adhesives - chemistry</topic><topic>Bioadhesive</topic><topic>Chemistry, Pharmaceutical</topic><topic>Controlled release</topic><topic>Delayed-Action Preparations - chemistry</topic><topic>Dexamethasone</topic><topic>Dexamethasone - analogs & derivatives</topic><topic>Dexamethasone - chemistry</topic><topic>Gels</topic><topic>Injections, Intraperitoneal</topic><topic>Intraperitoneal administration</topic><topic>Lidocaine</topic><topic>Lidocaine - chemistry</topic><topic>Poloxamer - chemistry</topic><topic>Poloxamer 407</topic><topic>Temperature</topic><topic>Thermoreversible gel</topic><topic>Viscosity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arbelaez-Camargo, Diana</creatorcontrib><creatorcontrib>Suñé-Negre, Josep Maria</creatorcontrib><creatorcontrib>Roig-Carreras, Manel</creatorcontrib><creatorcontrib>García-Montoya, Encarna</creatorcontrib><creatorcontrib>Pérez-Lozano, Pilar</creatorcontrib><creatorcontrib>Miñarro-Carmona, Montserrat</creatorcontrib><creatorcontrib>Ticó-Grau, Josep Ramon</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arbelaez-Camargo, Diana</au><au>Suñé-Negre, Josep Maria</au><au>Roig-Carreras, Manel</au><au>García-Montoya, Encarna</au><au>Pérez-Lozano, Pilar</au><au>Miñarro-Carmona, Montserrat</au><au>Ticó-Grau, Josep Ramon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preformulation and characterization of a lidocaine hydrochloride and dexamethasone sodium phosphate thermo-reversible and bioadhesive long-acting gel for intraperitoneal administration</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2016-02-10</date><risdate>2016</risdate><volume>498</volume><issue>1-2</issue><spage>142</spage><epage>152</epage><pages>142-152</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><abstract>[Display omitted]
The search for new formulations of anaesthetic agents that allow a localized administration and provide a prolonged effect is of great interest in the multimodal management of postoperative pain. The pre-formulation and characterization of a lidocaine and dexamethasone thermosensitive and bioadhesive long-acting gel for intraperitoneal administration was done as a tool in the management of pain in abdominal surgeries. The pre-formulation process was conducted by a systematic variation of the concentration of the different polymers, until setting it, in a suitable concentration that allowed an adequate gelation temperature. The poloxamer 407 (P407) was used as the main polymer; hydroxypropyl methylcellulose (HPMC) as the bioadhesive agent and polyvinyl pyrrolidone (PVP) to adjust the gelation temperature and physicochemical properties. The formulations were characterized by gelation temperature, pH, viscosity at 25°C and 37°C, gelation time, density and osmolality. Gelation temperature was decreased when increasing the concentration of hydroxypropyl methylcellulose and poloxamer 407, this effect was also observed when adding lidocaine hydrochloride and dexamethasone sodium phosphate to the formulations. The gelation temperature did not have statistically significant relation with the PVP concentration (P-value of 0.6797), even though, there is a tendency in the gelation temperature by varying it. Between the developed formulations, the 12.5/3.3/0.4% (P407/HPMC/PVP) formulation presents an appropriate gelation temperature, a suitable viscosity for administration by syringe, an adequate and stable pH and osmolality to prevent tissue damage and a correct gelation time that allowed the formation of a prolonged release implant.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>26685726</pmid><doi>10.1016/j.ijpharm.2015.12.012</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-6245-5666</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0378-5173 |
ispartof | International journal of pharmaceutics, 2016-02, Vol.498 (1-2), p.142-152 |
issn | 0378-5173 1873-3476 |
language | eng |
recordid | cdi_proquest_miscellaneous_1760930540 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Adhesiveness Adhesives - chemistry Bioadhesive Chemistry, Pharmaceutical Controlled release Delayed-Action Preparations - chemistry Dexamethasone Dexamethasone - analogs & derivatives Dexamethasone - chemistry Gels Injections, Intraperitoneal Intraperitoneal administration Lidocaine Lidocaine - chemistry Poloxamer - chemistry Poloxamer 407 Temperature Thermoreversible gel Viscosity |
title | Preformulation and characterization of a lidocaine hydrochloride and dexamethasone sodium phosphate thermo-reversible and bioadhesive long-acting gel for intraperitoneal administration |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T08%3A57%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preformulation%20and%20characterization%20of%20a%20lidocaine%20hydrochloride%20and%20dexamethasone%20sodium%20phosphate%20thermo-reversible%20and%20bioadhesive%20long-acting%20gel%20for%20intraperitoneal%20administration&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Arbelaez-Camargo,%20Diana&rft.date=2016-02-10&rft.volume=498&rft.issue=1-2&rft.spage=142&rft.epage=152&rft.pages=142-152&rft.issn=0378-5173&rft.eissn=1873-3476&rft_id=info:doi/10.1016/j.ijpharm.2015.12.012&rft_dat=%3Cproquest_cross%3E1760930540%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1760930540&rft_id=info:pmid/26685726&rft_els_id=S0378517315304130&rfr_iscdi=true |